A new way of thinking about metabolic health - The McKinsey Podcast Recap

Podcast: The McKinsey Podcast

Published: 2026-02-05

Duration: 17 min

Summary

This episode discusses the transformative potential of GLP-1 medications and the need for a broader approach to metabolic health that goes beyond merely treating obesity. It emphasizes the importance of societal engagement and innovation to achieve comprehensive metabolic health.

What Happened

In this episode, McKinsey partner Lars Hartenstein introduces the recent release of GLP-1 medications in pill form, highlighting their significant role in lowering blood sugar and reducing appetite. While these medications have proven to be revolutionary, Hartenstein cautions that they are not a cure-all for obesity or metabolic health issues. He asserts that this class of drugs represents the beginning of a larger conversation about metabolic health, which affects approximately one billion adults globally.

The discussion centers around the two paths outlined in a McKinsey report: one focused on treatment and the other on prevention. Hartenstein explains that the treatment-focused path leverages innovative drug classes to provide solutions for those already experiencing obesity. In contrast, the prevention-focused path aims for a more comprehensive approach to metabolic health for all, requiring systemic changes across various sectors, including healthcare, government, and communities. He notes that the latter path could yield health benefits three to four times greater than merely treating obesity, emphasizing the necessity for societal mobilization in this ambitious endeavor.

Key Insights

Key Questions Answered

What are GLP-1 medications and how do they work?

GLP-1 medications have recently been released in pill form, marking a significant innovation in diabetes treatment. They help to lower blood sugar levels and reduce appetite, making them a game changer in managing obesity and related health issues. However, Lars Hartenstein emphasizes that while they are an important tool in the healthcare arsenal, they are not a magic bullet for obesity or metabolic health.

Why is obesity considered a treatable disease now?

For many years, obesity was viewed as an intractable condition with limited options for treatment. The emergence of new classes of drugs, like GLP-1s, has shifted this perspective, allowing for more effective management of obesity. Hartenstein conveys that this change in viewpoint highlights the importance of addressing metabolic health as a broader issue that encompasses more than just obesity.

What is the difference between treatment-focused and prevention-focused approaches to metabolic health?

The treatment-focused approach primarily addresses individuals already living with obesity or at significant risk, leveraging innovations like new medications. Conversely, the prevention-focused path aims to provide metabolic health for all individuals and requires investments and leadership across multiple sectors, including healthcare, education, and government. This approach is deemed more ambitious and essential for long-term health improvements.

What are the five shifts needed for a metabolic health revolution?

Hartenstein outlines five crucial shifts necessary for achieving a metabolic health revolution: advancing science to define metabolic health, increasing transparency about individual metabolic health, leveraging technology for personalized health solutions, aligning economic incentives to promote healthier choices, and fostering societal change through education and engagement. These shifts are essential for creating an environment that supports better metabolic health outcomes.

Can you provide examples of successful health initiatives?

One notable example is Singapore's government initiative to increase physical activity among its population through a step challenge. This program has engaged a large number of participants over the past decade and aims to combat sedentary lifestyles, which contribute to obesity and metabolic health issues. Another example is the Yooka app, which allows users to scan barcodes for nutritional information, promoting better dietary choices.